NasdaqCM - Nasdaq Real Time Price USD
Anebulo Pharmaceuticals, Inc. (ANEB)
0.9950
+0.0250
+(2.58%)
As of 10:08:24 AM EDT. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-6,646.0500
-8,090.8490
-9,683.1330
-5,437.1740
-4,871.1890
Financing Cash Flow
15,000
-62.3540
6,382.0650
--
21,831.8540
End Cash Position
14,998.4670
3,094.2000
11,247.4030
14,548.4710
19,985.6450
Interest Paid Supplemental Data
--
--
--
--
13.0530
Issuance of Capital Stock
15,000
--
6,646.7480
--
22,854.7700
Repayment of Debt
--
--
--
--
-201.2860
Free Cash Flow
-6,646.0500
-8,090.8490
-9,683.1330
-5,437.1740
-4,871.1890
6/30/2021 - 5/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
23J0.F ProMIS Neurosciences, Inc.
0.5150
-4.63%
4A3.F Immatics N.V.
3.9300
+2.13%
M8W.F MediWound Ltd.
15.60
+0.65%
DRUG.CN Bright Minds Biosciences Inc.
47.48
0.00%
SRZN Surrozen, Inc.
10.58
+7.03%
PMVP PMV Pharmaceuticals, Inc.
1.0700
0.00%
PYPD PolyPid Ltd.
2.6700
-2.91%
BNTC Benitec Biopharma Inc.
14.08
+3.07%
IKNA Ikena Oncology, Inc.
1.2000
-0.83%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.0648
+2.05%